Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 0 | 16,146 | 0 | 0 |
| Cost of Goods | N/A | N/A | 475 | N/A | 0 |
| Gross Profit | N/A | N/A | 15,671 | N/A | N/A |
| Operating Expenses | 23,754 | 20,032 | 21,751 | 17,767 | 25,354 |
| Operating Income | -23,754 | -20,032 | -5,605 | -17,767 | -25,354 |
| Other Income | 2,551 | 2,731 | 2,349 | 2,170 | 2,305 |
| Pre-tax Income | -21,203 | -17,301 | -3,256 | -15,597 | -23,049 |
| Net Income Continuous | -21,203 | -17,301 | -3,256 | -15,597 | -23,049 |
| Net Income | $-21,203 | $-17,301 | $-3,256 | $-15,597 | $-23,049 |
| EPS Basic Total Ops | -0.35 | -0.29 | -0.06 | -0.34 | -0.56 |
| EPS Basic Continuous Ops | -0.35 | -0.29 | -0.06 | -0.33 | -0.56 |
| EPS Diluted Total Ops | -0.35 | -0.29 | -0.06 | -0.34 | -0.56 |
| EPS Diluted Continuous Ops | -0.35 | -0.29 | -0.06 | -0.33 | -0.56 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.29 | -0.06 | N/A | N/A |
| EBITDA(a) | $-24,675 | $-21,083 | $-5,777 | $-18,518 | $-26,311 |